Cover Image

Application of physiologically based pharmacokinetic modeling in predicting drug–drug interactions for sarpogrelate hydrochloride in humans

Jee Sun Min,1 Doyun Kim,1 Jung Bae Park,1 Hyunjin Heo,1 Soo Hyeon Bae,2 Jae Hong Seo,1 Euichaul Oh,1 Soo Kyung Bae1 1Integrated Research Institute of Pharmaceutical Sciences, College of Pharmacy, The Catholic University of Korea, Bucheon, 2Department of Pharmacology, College of Medicine, The Catholi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min JS (Author), Kim D (Author), Park JB (Author), Heo H (Author), Bae SH (Author), Seo JH (Author), Oh E (Author), Bae SK (Author)
Format:	Book
Published:	Dove Medical Press, 2016-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer
by: Park G, et al.
Published: (2017)

Drug–Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats
by: Wang Q, et al.
Published: (2019)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
by: Asiimwe IG, et al.
Published: (2022)

Pharmacokinetic-Based Drug–Drug Interactions with Anaplastic Lymphoma Kinase Inhibitors: A Review
by: Zhao D, et al.
Published: (2020)

Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions
by: Min-Koo Choi, et al.
Published: (2021)

Physiologically‐based pharmacokinetic model of sparsentan to evaluate drug-drug interaction potential
by: Nikunjkumar K. Patel, et al.
Published: (2024)

Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of Phenytoin
by: Leyanis Rodriguez-Vera, et al.
Published: (2023)

Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate
by: Seo JH, et al.
Published: (2015)

Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug-Drug and Drug-Disease Interactions of Apatinib
by: Hongrui Liu, et al.
Published: (2021)

Application of Physiologically‐Based Pharmacokinetic Modeling to Predict Gastric pH‐Dependent Drug-Drug Interactions for Weak Base Drugs
by: Zhongqi Dong, et al.
Published: (2020)

Establishment and Verification of UPLC-MS/MS Technique for Pharmacokinetic Drug–Drug Interactions of Selinexor with Posaconazole in Rats
by: Zhou C, et al.
Published: (2021)

Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling
by: Tao Ji, et al.
Published: (2022)

Prediction of Pharmacokinetic Drug–Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic Modeling
by: Bu F, et al.
Published: (2024)

Physiologically‐Based Pharmacokinetic Model‐Informed Drug Development for Fenebrutinib: Understanding Complex Drug‐Drug Interactions
by: Yuan Chen, et al.
Published: (2020)

Comparative study of antiretroviral drug regimens and drug–drug interactions between younger and older HIV-infected patients at a tertiary care teaching hospital in South Korea
by: Park MS, et al.
Published: (2018)

A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug-Drug Interaction Perpetrators
by: Fatima Zahra Marok, et al.
Published: (2023)

Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models
by: Zhiheng Yu, et al.
Published: (2022)

Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug-drug interactions
by: Gareth J. Lewis, et al.
Published: (2024)

Physiologically based pharmacokinetic modeling of imatinib and N‐desmethyl imatinib for drug-drug interaction predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2024)

A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug-drug interactions
by: Christina Kovar, et al.
Published: (2024)

Prediction of Drug-Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation
by: Deok Yong Yoon, et al.
Published: (2021)

Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018)

Prediction of the Drug-Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model
by: Zhuodu Wei, et al.
Published: (2023)

Drug-drug interaction prediction of ziritaxestat using a physiologically based enzyme and transporter pharmacokinetic network interaction model
by: Jeremy Perrier, et al.
Published: (2023)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
by: Lozano R, et al.
Published: (2013)

Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study
by: Tompson DJ, et al.
Published: (2014)

Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
by: Moore N, et al.
Published: (2015)

Evaluation of the drug-drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach
by: Michael J. Hanley, et al.
Published: (2024)

Physiologically‐based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patients
by: Magali Amiel, et al.
Published: (2024)

Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy
by: Shakir Atoyebi, et al.
Published: (2024)

Investigating Transporter‐Mediated Drug‐Drug Interactions Using a Physiologically Based Pharmacokinetic Model of Rosuvastatin
by: Q Wang, et al.
Published: (2017)

Quantitative Prediction of Drug-Drug Interactions Involving Inhibitory Metabolites by Physiologically Based Pharmacokinetic Models: Is it Worth It?
by: M Tod, et al.
Published: (2017)

Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2023)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
by: Lozano R, et al.
Published: (2013)

Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
by: Ghasemiyeh P, et al.
Published: (2020)

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine
by: Lien Thi Ngo, et al.
Published: (2022)

Physiologically‐based pharmacokinetic modeling to predict CYP3A4‐mediated drug‐drug interactions of finerenone
by: Thomas Wendl, et al.
Published: (2022)

A physiologically‐based pharmacokinetic/pharmacodynamic modeling approach for drug-drug‐gene interaction evaluation of S‐warfarin with fluconazole
by: Kuo Geng, et al.
Published: (2024)

Applied physiologically‐based pharmacokinetic modeling to assess uridine diphosphate‐glucuronosyltransferase‐mediated drug-drug interactions for Vericiguat
by: Sebastian Frechen, et al.
Published: (2024)

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene-Drug-Drug Interactions
by: Flavia Storelli, et al.
Published: (2019)